ALYSSA JACK: Open Payments
NPI 1598357436 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,141 in 50 payments from 9 companies in 2025. Trend: 2023 $252 · 2024 $1,807 · 2025 $1,141
Food & beverage: $967Education: $174
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 22 | $428 |
| Janssen Biotech, Inc. | 7 | $257 |
| UCB, Inc. | 10 | $180 |
| Lilly USA, LLC | 4 | $133 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Alexion Pharmaceuticals, Inc. | 1 | $27 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| ANI Pharmaceuticals, Inc. | 1 | $19 |
Products named: TREMFYA, Bimzelx, TAVNEOS, TALTZ, OTEZLA, REPATHA, ENBREL, COSENTYX.
Industry payments across ID — which companies pay providers there.
